{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-052908","form_type":"8-K","ticker":"BMY","cik":"0000014272","company_name":"BRISTOL MYERS SQUIBB CO","filed_at":"2023-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.038126+00:00","generated_at":"2026-06-08T04:51:24.223506+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Bristol-Myers Squibb completes $4.5B note offering to finance Mirati acquisition","bullets":["$4.5B note offering completed: $1B 5.75% due 2031, $1B 5.9% due 2033, $1.25B 6.25% due 2053, $1.25B 6.4% due 2063.","Proceeds to fund general corporate purposes, including the proposed acquisition of Mirati Therapeutics.","Offering closed November 13, 2023; underwritten by syndicate of banks."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-052908","json":"https://secwatch.observer/filing/0001140361-23-052908.json","markdown":"https://secwatch.observer/filing/0001140361-23-052908.md","text":"https://secwatch.observer/filing/0001140361-23-052908.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/14272/000114036123052908/0001140361-23-052908-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/14272/000114036123052908/ny20014138x1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T04:51:24.223506+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}